Estimation of Symptom Severity During Chemotherapy From Passively Sensed Data: Exploratory Study
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Physical and psychological symptoms are common during chemotherapy in cancer patients, and real-time monitoring of these symptoms can improve patient outcomes. Sensors embedded in mobile phones and wearable activity trackers could be potentially useful in monitoring symptoms passively, with minimal patient burden. OBJECTIVE: The aim of this study was to explore whether passively sensed mobile phone and Fitbit data could be used to estimate daily symptom burden during chemotherapy. METHODS: A total of 14 patients undergoing chemotherapy for gastrointestinal cancer participated in the 4-week study. Participants carried an Android phone and wore a Fitbit device for the duration of the study and also completed daily severity ratings of 12 common symptoms. Symptom severity ratings were summed to create a total symptom burden score for each day, and ratings were centered on individual patient means and categorized into low, average, and high symptom burden days. Day-level features were extracted from raw mobile phone sensor and Fitbit data and included features reflecting mobility and activity, sleep, phone usage (eg, duration of interaction with phone and apps), and communication (eg, number of incoming and outgoing calls and messages). We used a rotation random forests classifier with cross-validation and resampling with replacement to evaluate population and individual model performance and correlation-based feature subset selection to select nonredundant features with the best predictive ability. RESULTS: Across 295 days of data with both symptom and sensor data, a number of mobile phone and Fitbit features were correlated with patient-reported symptom burden scores. We achieved an accuracy of 88.1% for our population model. The subset of features with the best accuracy included sedentary behavior as the most frequent activity, fewer minutes in light physical activity, less variable and average acceleration of the phone, and longer screen-on time and interactions with apps on the phone. Mobile phone features had better predictive ability than Fitbit features. Accuracy of individual models ranged from 78.1% to 100% (mean 88.4%), and subsets of relevant features varied across participants. CONCLUSIONS: Passive sensor data, including mobile phone accelerometer and usage and Fitbit-assessed activity and sleep, were related to daily symptom burden during chemotherapy. These findings highlight opportunities for long-term monitoring of cancer patients during chemotherapy with minimal patient burden as well as real-time adaptive interventions aimed at early management of worsening or severe symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Basch, E., Deal, A. M., Kris, M. G., Scher, H. I., Hudis, C. A., Sabbatini, P., Rogak, L., Bennett, A. V., Dueck, A. C., Atkinson, T. M., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.0830 · Cited by 2,593 · cited 1×
“During outpatient treatment, such as chemotherapy, remote real-time monitoring of symptoms can enhance patient-provider communication and prevent potentially life-threatening adverse effects [3,4].”
BackgroundThomée, S., Härenstam, A., & Hagberg, M. (2011) · BMC Public Health · doi:10.1186/1471-2458-11-66 · Cited by 1,269 · cited 1×
“The finding that greater symptom severity was related to greater phone use duration is consistent with studies linking depressive symptoms and mobile phone use [13,22].”
ResultWang, R., Chen, F., Chen, Z., Li, T., Harari, G., Tignor, S., Zhou, X., Ben-Zeev, D., & Campbell, A. T. (2014) · Proceedings of the 2014 ACM International Joint Conference on Pervasive and Ubiquitous Computing · doi:10.1145/2632048.2632054 · Cited by 1,116 · cited 2×
“First, we focused on patients undergoing outpatient chemotherapy treatment, a group that is likely to be older, less comfortable with technology, and more physically ill than samples of undergraduates [14] and young adults [13] in which mobile phone sensors have previously been linked to depressive symptoms.”
BackgroundSaeb, S., Zhang, M., Karr, C. J., Schueller, S. M., Corden, M. E., Kording, K. P., & Mohr, D. C. (2015) · Journal of Medical Internet Research · doi:10.2196/jmir.4273 · Cited by 782 · cited 5×
“The finding that greater symptom severity was related to greater phone use duration is consistent with studies linking depressive symptoms and mobile phone use [13,22].”
BackgroundResultInfluentialAWARE: Mobile Context Instrumentation Framework
Ferreira, D., Kostakos, V., & Dey, A. K. (2015) · Frontiers in ICT · doi:10.3389/fict.2015.00006 · Cited by 409 · cited 1×
“The AWARE framework was installed on the phone [16].”
MethodSelf-citationDirect Measurements of Smartphone Screen-Time: Relationships with Demographics and Sleep
Christensen, M. A., Bettencourt, L., Kaye, L., Moturu, S. T., Nguyen, K. T., Olgin, J. E., Pletcher, M. J., & Marcus, G. M. (2016) · PLOS ONE · doi:10.1371/journal.pone.0165331 · Cited by 327
Kearney, N., McCann, L., Norrie, J., Taylor, L., Gray, P., McGee-Lennon, M., Sage, M., Miller, M., & Maguire, R. (2009) · Supportive Care in Cancer · doi:10.1007/s00520-008-0515-0 · Cited by 263 · cited 1×
“Some of these systems include alerts to clinicians if patient-reported symptoms exceed a certain severity threshold [8,9] or tailored self-management support triggered by reported symptoms [10].”
BackgroundSmartphone data as an electronic biomarker of illness activity in bipolar disorder
Faurholt‐Jepsen, M., Vinberg, M., Frost, M., Christensen, E. M., Bardram, J. E., & Kessing, L. V. (2015) · Bipolar Disorders · doi:10.1111/bdi.12332 · Cited by 169
Cited by
The impact of wearable technologies in health research: scoping review
Huhn, S., Axt, M., Gunga, H.-C., Maggioni, M. A., Munga, S., Obor, D., Sié, A., Boudo, V., Bunker, A., Sauerborn, R., et al. (2022) · JMIR mHealth and uHealth · doi:10.2196/34384 · Cited by 379
Digital health for optimal supportive care in oncology: benefits, limits, and future perspectives
Aapro, M., Bossi, P., Dasari, A., Fallowfield, L., Gascón, P., Geller, M., Jordan, K., Kim, J., Martin, K., & Porzig, S. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05539-1 · Cited by 311
Personalized Models of Psychopathology
Wright, A. G. C., & Woods, W. C. (2020) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-102419-125032 · Cited by 264
Harnessing consumer smartphone and wearable sensors for clinical cancer research
Low, C. A. (2020) · npj Digital Medicine · doi:10.1038/s41746-020-00351-x · Cited by 120
Self-citationThe Use of Wearables in Clinical Trials During Cancer Treatment: Systematic Review
Beauchamp, U. L., Pappot, H., & Holländer-Mieritz, C. (2020) · JMIR mHealth and uHealth · doi:10.2196/22006 · Cited by 110
Metadata
- Authors
- Low, C. A., Dey, A. K., Ferreira, D., Kamarck, T., Sun, W., Bae, S., & Doryab, A.
- Venue
- Journal of Medical Internet Research
- Publisher
- JMIR Publications Inc.
- Published
- 2017-12-19
- Volume
- 19
- Issue
- 12
- Pages
- e420
- ISSN
- 1438-8871 (ISSN-L)
- OpenAlex
- W2781276926
- Cited by
- 66
- References
- 8
- FWCI
- 8.68
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.